[Note from SaneVax: Here you have it in writing. HPV vaccination of boys as a ‘case study’ for the world. Are the citizens of Australia being warned that their young male population may soon be the target of a clinical trial?]
By Staff Writer, Star Online
The authors of a new paper on human papillomavirus (HPV) vaccination for males say other countries will benefit if Australia goes ahead with vaccinating boys.
Researchers Melina Georgousakis, Sanjay Jayasinghe, Julia Brotherton, Nicole Gilroy, Clayton Chiu and Kristine Macartney published ‘Population-wide vaccination against HPV in adolescent boys: Australia as a case study’ in The Lancet on March 23.
“The experiences and data gained over time from countries where universal male vaccination is introduced will be essential to further understand the impact of dual-sex HPV vaccination,” the paper found.
“Australia is the best case study because we’re so far ahead of every other country in the world in immunising girls,” Kirby Institute Sexual Health Program head Professor Basil Donovan said.
Access The Lancet abstract here (fee applies for complete paper).
Leave a Reply